Build a Better Process
Stock Risk Measures for Bristol-Myers Squibb Co
A quantitative factor review, as of September 30, 2020.
- Company Info - Description, identity and sector data.
- Share Data - Stock earnings and key dates.
- Market Risk - Beta, size, liquidity and momentum measures.
- Financial Risk - Earnings and dividends.
Updated: October 01, 2020
See how we arrive at an overall risk score of
for BMY below.
An ad-free and cookie-free webpage by FactorPad
BMY Risk Report
Our quantitative data points are meant to provide a high-level understanding of
factors in equity risk models for Bristol-Myers Squibb Co. Portfolio managers use these
models to forecast risk, optimize portfolios and review performance.
We show how BMY stock compares to 2,000+ US-based stocks, and to
peers in the Health Technology sector and Pharmaceuticals: Major industry.
Please do not consider this data as investment advice. Data is downloaded from
sources we deem reliable, but errors may occur.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
- Symbol: BMY
- FactorPad FPID: f21vqf
- SEC CIK: 0000014272
- Share Class FIGI: BBG001S8N8J6
- Location: New York, NY US
- Web: http://www.bms.com
- Employees: 30,000
Sector and Industry
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
- SIC Code: 2834
Shares and Float
- Shares Outstanding: 2,253,930,000
- Shares Trading: 2,251,989,366
- Percent Trading: 99.9 %
Earnings and Dividends
- Trailing 12-month earnings: -0.1
- Next earnings date: 2020-11-05
- Dividends in last 12 months: 1.76
- Ex-dividend date: 2020-10-01
Market Risk Measures
Many of the following risk metrics are standardized and transformed into
quantitative factors in institutional-level risk models.
Rankings below represent percentiles from 1 to 100, with 1 being the lowest
rating of risk.
Stocks with higher beta exhibit higher sensitivity to the ups and downs
in the market. (↑↑)
Beta: 0.61 |
Stocks with higher market capitalization often have lower risk. (↑↓)
Market Capitalization: $135,889,439,700 |
Higher average daily dollar volume over the past 30 days implies lower
liquidity risk. (↑↓)
Daily Dollar Volume: $597,078,454 |
Higher price momentum stocks, aka recent winners, equate to lower risk for many
Stock Price Change (1-Year): 19.03% |
Financial Risk Measures
Style risk factors often include measures of profitability and payout levels.
Companies with higher earnings generally provide lower risk. (↑↓)
Earnings Yield (E/P): -0.17% |
Companies with higher dividend yields, if sustaintable, are perceived to
have lower risk. (↑↓)
Dividend Yield (D/P): 2.92% |
BMY stock risk
BRISTOL-MYERS SQUIBB CO stock beta
BMY risk report
BMY risk analysis
BRISTOL-MYERS SQUIBB CO credit risk
BMY liquidity risk
BMY systematic risk
BMY specific risk
BRISTOL-MYERS SQUIBB CO volatility
BMY financial ratio
This is a new resource, spread the word, tell a friend